15/10/2021 - 14:00

Dimerix starts COVID-19 drug trials

15/10/2021 - 14:00

Bookmark

Upgrade your subscription to use this feature.

Perth-founded biopharmaceutical business Dimerix has launched phase three drug trials for patients with COVID-19 and kidney diseases.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options